Inflammatory phenotyping predicts clinical outcome in COVID-19
Research
[키워드] 95% CI
Accuracy
addition
Admission
adverse outcome
Analysis
AUROC
benefit
Clinical data
Clinical outcome
clinical parameter
collected
COVID-19
COVID-19 pandemic
COVID-19 patient
cytokine
cytokine level
death
demographic
demonstrated
Deterioration
diagnosis of SARS-CoV-2
disease severity
GM-CSF
greater
help
hospitalised patient
hyperinflammation
Hyperinflammatory
identification
identify
IFN-γ
IL-10
IL-1β
IL-33
IL-6
IL-8
immunomodulatory
IMPROVE
Infection
multiplex
outcome
Patient
point-of-care testing
predict
Predictive
Result
risk
SARS-CoV-2
serum
significantly
subgroup
TNF
TNF-α
Treatment
Trial
university
[DOI] 10.1186/s12931-020-01511-z PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12931-020-01511-z PMC 바로가기 [Article Type] Research